AVI BioPharma, Inc. (AVII) Tops Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts AVII Hot Sheet
Price: $0.66 --0%
Financial Fact:
Research and development: 34.35M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Research and development: 34.35M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
AVI BioPharma, Inc. (NASDAQ: AVII) reported Q2 EPS of $0.01, $0.08 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $11.6 million versus the consensus estimate of $13.67 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- XP Inc. (XP) Tops Q2 EPS by 8c
- INVO Fertility (IVF) Tops Q2 EPS by 105c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
